In an ideal world, there would be exactly enough drug at each clinical site around the globe to ensure the study runs smoothly. No wasted supply and no risk of trial disruption. Unfortunately, this is not an ideal world but rather the real world of increasingly complex clinical trials.
Your RTSM plays a critical role by requesting the right medication, at the right time and in the right quantity. Shouldn’t your RTSM also enable real-time visibility, scenario planning and control over supply decisions?
Avoid stock-outs by covering upcoming demand (predictable and unpredictable) through intuitive dials managing both short and long-window.
See the impact of supply decisions on buffer levels, shipping size/storage capacity, before committing the settings.
Dynamically adapt to demand with real-time buffer calculations for sites and depots.
RTSM/clinical supply forecasting integration allows resupply calculations to follow the course of the study.
4G Clinical's Amy Ripston discusses the rising complexities of randomization and trial supply management in rare disease trials.
Catherine Hall, director, operational excellence, Sunovion discusses how IRT systems (Interactive Response Technologies) bridges clinical and supply.
4G's Pirmin Froehlicher offers best practices on clinical supply forecasting, reducing supply chain risk and clinical supply waste.
Seeing is believing. Let us show you first-hand how Prancer enables faster, more flexible and higher quality systems.
Start a conversation today. Our data sheet provides a snapshot of 4G's differentiators and exceptional services.
User Acceptance Testing and
RTSM System Validation
Demonstrating Joint Responsibility (Vendor and Sponsor) for Ensuring RTSM Validation in a Highly-Regulated Environment
Best Practices for Randomization and Trial Supply Management (RTSM)
Guidelines for Sponsor IRT Strategy – Study Start-Up, Maintenance and Close-Out
Should Technology Vendors
Sit at the Sponsor Table?
The Power of RTSM Problem
Solvers on Your Team